Area of research
Pulmonary and Respiratory Medicine · Sociology and Political Science
Research interest
Research focused on Cystic fibrosis and Exacerbation, with related work in Lung function, Ivacaftor, Antibiotics. Notable publications include 'Sustained Benefit from Ivacaftor Demonstrated by Combining Clinical Trial and Cystic Fibrosis Patient Registry Data', 'Risk factors for rate of decline in FEV1 in adults with cystic fibrosis', and 'Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis'.
Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis
Relationship of Antibiotic Treatment to Recovery after Acute FEV1 Decline in Children with Cystic Fibrosis
Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation
Strengthening care teams to improve adherence in cystic fibrosis: a qualitative practice assessment and quality improvement initiative
Sustained Benefit from Ivacaftor Demonstrated by Combining Clinical Trial and Cystic Fibrosis Patient Registry Data
Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function
Probability of Treatment Following Acute Decline in Lung Function in Children with Cystic Fibrosis is Related to Baseline Pulmonary Function
Risk factors for rate of decline in FEV1 in adults with cystic fibrosis
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis
Pulmonary exacerbations in cystic fibrosis: Young children with characteristic signs and symptoms